Zullino, Daniele Fabio <br/><br/>
Increased risk of gastrointestinal adverse effects under SSRI/NSAID combination may be due to pharmacokinetic interactions.  [electronic resource] 

 -  British journal of clinical pharmacology  Jan 2005 
 - 118-9; author reply 119 p.  digital 
<br/><br/> Publication Type: Comment; Letter 
<br/><br/><label>ISSN: </label>0306-5251 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2125.2005.2212_1.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Inflammatory Agents, Non-Steroidal--adverse effects<br/>Antidepressive Agents, Tricyclic--adverse effects<br/>Aryl Hydrocarbon Hydroxylases--antagonists & inhibitors<br/>Cytochrome P-450 CYP2C9<br/>Drug Combinations<br/>Gastrointestinal Diseases--chemically induced<br/>Humans<br/>Selective Serotonin Reuptake Inhibitors--adverse effects